Some providers featured on this site may compensate us. This may affect the order and placement of listings but does not influence our editorial ratings or reviews.
Treatments Hub

Verified prices

All verified prices
Science9 min read

Ozempic vs Wegovy (2026): Same Drug, Different Uses - Full Guide

Ozempic and Wegovy both contain semaglutide but aren't the same. We compare FDA approval, dosing, weight loss results, cost, insurance, and how to get them online.

Updated September 15, 2026

Medically reviewed on

How we review

The quick answerOzempic and Wegovy contain the same active ingredient (semaglutide) but are not the same drug: Ozempic is FDA-approved for type 2 diabetes, Wegovy for chronic weight management at a higher maximum dose (2.4 mg vs 2 mg). For self-pay weight loss, compounded semaglutide runs a verified $41-$99/month versus $1,149+ for either brand.Prices verified on each provider’s site as of November 3, 2026.

Same Ingredient, Different FDA Approval

An Ozempic (semaglutide) injection pen next to a Wegovy 2.4 mg (semaglutide) injection pen on a kitchen counter, comparing the two semaglutide brands

Ozempic and Wegovy both contain semaglutide, a GLP-1 receptor agonist manufactured by Novo Nordisk. The critical difference is their FDA-approved purpose.

Ozempic is approved for type 2 diabetes management. Wegovy is approved specifically for chronic weight management.

Many doctors prescribe Ozempic off-label for weight loss, but Wegovy was designed, dosed, and clinically tested specifically for that purpose.

Our top 2 picks

Our two recommended GLP-1 providers, shown with the same verified pricing and ratings as our full comparison.

Our Top Pick
1
embody logo

Exceptional

9.8out of 10

Compounded GLP-1 from $49/month; not FDA-approved, free expedited delivery

Free expedited deliveryNo hidden fees
  • Compounded semaglutide ($49/mo) and tirzepatide ($99/mo) as shown on the homepage, Nov 16, 2026; not FDA-approved
  • Online intake, then a prescriber review by OpenLoop Health, a network of US-licensed doctors
  • Free expedited delivery (embody's words); the Terms do not guarantee a delivery timeline
  • No insurance required, no clinic visits; cancel at least 72 hours before the next billing date

from $49/month

Doctor-prescribed compounded GLP-1 treatment, not FDA-approved: semaglutide shown at $49/month and tirzepatide at $99/month on embody's homepage (Nov 16, 2026), no insurance required.

Read full embody review
2
altRx logo

Excellent

9.4out of 10

Most Comprehensive GLP-1 Medication Access

Transparent pricingNo insurance required
  • Compounded GLP-1 from $89/mo, GLP-1 + GIP from $149/mo
  • Brand-name options too: Zepbound and Wegovy
  • Clinician-guided - physician, PA, or nurse practitioner
  • Free shipping (about 5-7 days)

from $89/month

Affordable GLP-1 program from $89/month - compounded semaglutide and tirzepatide plus brand-name options - with clinician-guided, self-pay care and no insurance required.

Read full altRx review

Dosing: Wegovy Goes Higher

Ozempic's maximum dose is 2 mg per week. Wegovy goes up to 2.4 mg per week - a 20% higher maximum dose.

Both use a gradual titration schedule over 16-20 weeks to minimize side effects, starting at a low dose and increasing monthly. Wegovy's extra dosing tier is one reason it tends to produce more significant weight loss in clinical trials.

For a week-by-week look at what starting treatment feels like, see our first month guide.

Weight Loss Results Compared

In the STEP clinical trials, Wegovy patients lost an average of about 15% of their body weight over 68 weeks. Ozempic trials (which focused on diabetes outcomes) showed average weight loss of around 10-12%.

For a 200-pound person, that's roughly 30 lbs with Wegovy vs 20-24 lbs with Ozempic. Both produce meaningful results, but Wegovy's higher dose and weight-specific design give it a consistent edge.

Curious how these compare to tirzepatide? See our Mounjaro vs Ozempic comparison.

Side Effects: Essentially the Same

Since both contain the same active ingredient, the side effect profiles are nearly identical. The most common issues are gastrointestinal: nausea (40-45% of patients), diarrhea (~30%), vomiting (~25%), and constipation (~24%).

These are typically most pronounced during dose increases and improve over time. Wegovy's slightly higher maximum dose may cause somewhat more GI issues at the top end.

For detailed management strategies, read our semaglutide side effects guide.

What To Know Before Starting GLP-1 Treatment

Before starting GLP-1 treatment, it's important to understand a few key things. These medications require a prescription from a licensed clinician and aren't suitable for everyone. Some people may experience side effects, especially during the first few weeks as the body adjusts.

GLP-1s also tend to work best when combined with basic lifestyle habits like balanced nutrition and regular physical activity.

That's why choosing a provider that offers proper medical screening and ongoing follow-up support is essential for both safety and long-term success.

Woman preparing GLP-1 weight loss injection

Cost: Brand-Name vs Compounded

Ozempic costs approximately $900-$1,000/month at retail. Wegovy is more expensive at $1,300-$1,400/month.

Insurance is more likely to cover Ozempic (as a diabetes drug) than Wegovy (as a weight loss drug). However, many patients skip both brand names entirely and access compounded semaglutide through telehealth providers for $199-$400/month - same active ingredient, significantly lower cost.

For a full breakdown, see our semaglutide monthly cost guide and complete pricing comparison.

Shop semaglutide plans by provider

Published semaglutide plans - cheapest first, conditions under each price.

Insurance Coverage Reality

Ozempic has better insurance coverage because it's classified as a diabetes medication with established treatment guidelines. Wegovy, as a weight loss drug, is frequently excluded from formularies or requires prior authorization.

Even when covered, copays can be substantial. For patients without coverage, compounded semaglutide through telehealth is the most practical path.

See our guide on getting weight loss medication without insurance.

Compounded Semaglutide: The Third Option

Most patients actually access semaglutide through a third path: compounded versions from licensed telehealth providers. Compounded semaglutide uses the same active ingredient as Ozempic and Wegovy but costs a fraction of the price.

It's not individually FDA-approved but is produced by licensed compounding pharmacies under FDA regulation. Read our full compounded vs brand-name guide to understand the trade-offs.

How to Get Semaglutide Online

Whether you want Ozempic, Wegovy, or compounded semaglutide, you can access it through licensed telehealth providers without visiting a doctor's office. The process takes 1-5 days from evaluation to delivery. Compare top providers on our platform, or read our step-by-step guide to getting Ozempic online.

Which Should You Choose?

If you have type 2 diabetes and want weight loss benefits, Ozempic addresses both. If weight loss is your sole goal and you have insurance that covers it, Wegovy is purpose-built. If you're paying out of pocket (most patients), compounded semaglutide from a telehealth provider offers the same active ingredient at the best price. Take our matching quiz to find the right provider, or compare semaglutide providers directly.

Ready to compare weight loss providers?

See how top providers stack up on pricing, medical support, and treatment options.

Medical disclaimer

This page is general information about GLP-1 weight-loss medications such as semaglutide and tirzepatide, published to help you compare services. It is not medical advice, it does not create a doctor-patient relationship, and it is not a substitute for a consultation with a licensed clinician who knows your history. Treatments Hub is not a medical provider, pharmacy or clinic and does not prescribe, sell or dispense medication. Do not start, stop or change any treatment because of something you read here, and do not delay seeking care; in an emergency call 911.

Semaglutide and tirzepatide carry an FDA boxed warning about thyroid C-cell tumours seen in rodents and are not for anyone with a personal or family history of medullary thyroid carcinoma or MEN 2, nor for use in pregnancy. Compounded versions sold by telehealth providers are prepared by state-licensed pharmacies and are not FDA-approved products. Where a review or post on this page mentions weight lost, that is one person's result and is not typical; results vary widely.

Medical and scientific statements on this site are checked against the sources linked on the page by our medical content reviewer, who does not choose providers or set prices. Prices, plans and customer reviews are each provider's published figures and customers' own words on the dates stated. We may earn a commission from provider links. The full medical and advertising disclaimer explains all of this in detail.

Sources & medical references

Treatment facts on this page are grounded in regulatory guidance and peer-reviewed research. Pricing and plan details come from each provider's published information. This content is for information only and is not medical advice - always consult a licensed clinician before starting treatment.

  1. 1.Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1 trial) - New England Journal of Medicine, 2021
  2. 2.Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1 trial) - New England Journal of Medicine, 2022
  3. 3.FDA Approves New Drug Treatment for Chronic Weight Management (semaglutide / Wegovy) - U.S. Food & Drug Administration, 2021
  4. 4.FDA Approves New Medication for Chronic Weight Management (tirzepatide / Zepbound) - U.S. Food & Drug Administration, 2023
  5. 5.FDA's Concerns with Unapproved GLP-1 Drugs Used for Weight Loss - U.S. Food & Drug Administration
  6. 6.Human Drug Compounding (503A pharmacy standards) - U.S. Food & Drug Administration
  7. 7.Semaglutide Injection - drug information - MedlinePlus, U.S. National Library of Medicine (NIH)